Health

Emergent knew of vaccine manufacturing issues as it collected millions


Emergent knew of vaccine manufacturing issues as it collected millions

Under a contract awarded by the Trump administration, Emergent BioSolutions (EBS) was paid $27 million a month to make Covid-19 vaccines, but the company already knew of serious quality control problems at its Baltimore plant, but failed to take any action, according to documents released by two House committees.

The manufacturing problems forced the company to destroy millions of doses of Johnson & Johnson (JNJ) Covid-19 vaccines earlier this year that were to have been made at the plant. In fact, a J&J audit conducted shortly after the contract was awarded found potential “weaknesses” and a “deficient” strategy for controlling contamination.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED




Source link

Back to top button